Trivedi, Vrunda
Yang, Changlin
Klippel, Kelena
Yegorov, Oleg
von Roemeling, Christina
Hoang-Minh, Lan
Fenton, Graeme
Ogando-Rivas, Elizabeth
Castillo, Paul
Moore, Ginger
Long-James, Kaytora
Dyson, Kyle
Doonan, Bently
Flores, Catherine
Mitchell, Duane A. http://orcid.org/0000-0001-6049-213X
Funding for this research was provided by:
National Institutes of Health (R01CA195563)
University of Florida Health Cancer Center (Predoctoral Award)
V Foundation for Cancer Research (Translational Research Award)
Adam Rosen Research Foundation
Clinical and Translational Science Institute, University of Florida (UL1 TR001427)
Cure Group 4 Medulloblastoma Consortium
Wells Foundation
Article History
Received: 14 April 2023
Accepted: 2 January 2024
First Online: 25 January 2024
Declarations
:
: Tissue from the GBM patient used in this study was received from a tumor bank provided by the Florida Center for Brain Tumor Research and approved under UF IRB protocol 201300482. The animal work performed in this study was approved by the University of Florida Institutional Animal Care and Use Committee (IACUC) under protocol id 202100000029.
: Not applicable.
: The authors declare no conflicts of interest with this work.